New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.

Analysts believe it could also rival Novo Nordisk, the pharmaceutical company whose products are emerging as the biggest selling anti-obesity drugs ... Orexigen's Mysimba/Contrave weight loss ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Impact on brown adipose tissue: Berberine may lower weight by increasing brown adipose tissue, a type of fat tissue that ...

New GLP-1RA weight loss drugs like Like Ozempic and Wegovy have become extremely popular in recent months but researchers ...

Rapid weight loss affects muscle mass and can increase the risk of osteoporosis. But now there is good news for people taking weight loss medication who may be at risk. A new study indicates that the ...

And considering the rising popularity of Ozempic and other weight loss drugs, that is bound to catch folks’ attention. Toss in the fact that you can grab a month’s supply of berberine off of ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...